Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)

NCT02577029 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

79

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision to discontinue trial

Conditions

Hepatitis B
Hepatitis D

Interventions

DRUG: ARC-520
DRUG: entecavir
BIOLOGICAL: pegylated interferon alpha 2a
DRUG: tenofovir disoproxil
DRUG: antihistamine

Sponsor

Arrowhead Pharmaceuticals